Jean-Pierre Vartanian

Dr. Jean-Pierre Vartanian


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1990 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AMAndreas Meyerhans
Andreas Meyerhans
JVJean-Pierre Vartanian
Jean-Pierre Vartanian
SWSimon Wain-Hobson
Simon Wain-Hobson
PCR co-amplification of two distinct HIV1 tat gene sequences lead to the formation of recombinant DNA molecules. The frequency of such recombinants, up to 5.4% of all amplified molecules, could be decreased 2.7 fold by a 6 fold increase In Taq DNA polymerase elongatlon time. Crossover sites mapped essentially to three discrete regions suggesting specific Taq DNA polymerase pause or termination sites. PCR mediated recombination may be a problem when studying heterogeneous genetic material such as RNA viruses, multigene families, or repetitive sequences. This phenomenon can be exploited to create chimeric molecules from related sequences.

11 July 2002 in Nature
Verified
Journal Article
Open access
PDF file
AJAndreas Jung
Andreas Jung
RMReinhard Maier
Reinhard Maier
JVJean-Pierre Vartanian
Jean-Pierre Vartanian
GBGennady Bocharov
Gennady Bocharov
VJVolker Jung
Volker Jung
AMAndreas Meyerhans
Andreas Meyerhans
The genome of the human immunodeficiency virus is highly prone to recombination1,2,3, although it is not obvious whether recombinants arise infrequently or whether they are constantly being spawned but escape identification because of the massive and rapid turnover of virus particles4,5. Here we use fluorescence in situ hybridization to estimate the number of proviruses harboured by individual splenocytes from two HIV patients, and determine the extent of recombination by sequencing amplified DNA from these cells. We find an average of three or four proviruses per cell and evidence for huge numbers of recombinants and extensive genetic variation. Although this creates problems for phylogenetic analyses, which ignore recombination effects, the intracellular variation may help to broaden immune recognition.

11 April 2008 in Science
Verified
Journal Article
Closed access
PDF file
JVJean-Pierre Vartanian
Jean-Pierre Vartanian
DGDenise GuétArd
Denise GuétArd
MHMichel Henry
Michel Henry
SWSimon Wain-Hobson
Simon Wain-Hobson
Cytidine deaminases of the APOBEC3 family all have specificity for single-stranded DNA, which may become exposed during replication or transcription of double-stranded DNA. Three human APOBEC3A ( hA3A ), hA3B , and hA3H genes are expressed in keratinocytes and skin, leading us to determine whether genetic editing of human papillomavirus (HPV) DNA occurred. In a study of HPV1a plantar warts and HPV16 precancerous cervical biopsies, hyperedited HPV1a and HPV16 genomes were found. Strictly analogous results were obtained from transfection experiments with HPV plasmid DNA and the three nuclear localized enzymes: hA3A, hA3C, and hA3H. Thus, stochastic or transient overexpression of APOBEC3 genes may expose the genome to a broad spectrum of mutations that could influence the development of tumors.

26 May 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RSRodolphe Suspène
Rodolphe Suspène
DGDenise Guétard
Denise Guétard
MHMichel Henry
Michel Henry
PSPeter Sommer
Peter Sommer
SWSimon Wain-Hobson
Simon Wain-Hobson
JVJean-Pierre Vartanian
Jean-Pierre Vartanian
Because the replication of hepatitis B virus (HBV) proceeds via an obligatory reverse transcription step in the viral capsid, cDNA is potentially vulnerable to editing by cytidine deaminases of the APOBEC3 family. To date only two edited HBV genomes, referred to as G → A hypermutants, have been described in vivo . Recent work suggested that HBV replication was indeed restricted by APOBEC3G but by a mechanism other than editing. The issue of restriction has been explored by using a sensitive PCR method allowing differential amplification of AT-rich DNA. G → A hypermutated HBV genomes were recovered from transfection experiments involving APOBEC3B, -3C, -3F, and -3G indicating that all four enzymes were able to extensively deaminate cytidine residues in minus-strand DNA. Unexpectedly, three of the four enzymes (APOBEC3B, -3F, and -3G) deaminated HBV plus-strand DNA as well. From the serum of two of four patients with high viremia, G → A hypermutated genomes were recovered at a frequency of ≈10 -4 , indicating that they are, albeit relatively rare, part of the natural cycle of HBV infection. These findings suggest that human APOBEC3 enzymes can impact HBV replication via cytidine deamination.

25 May 2006 in Hepatology
Verified
Journal Article
Open access
PDF file
MBMarianne Bonvin
Marianne Bonvin
FAFrançois Achermann
François Achermann
IGIsabell Greeve
Isabell Greeve
DSDeborah Stroka
Deborah Stroka
AKAdrian Keogh
Adrian Keogh
JGJobst Greeve
Jobst Greeve
Hypermutations in hepatitis B virus (HBV) DNA by APOBEC3 cytidine deaminases have been detected in vitro and in vivo, and APOBEC3G (A3G) and APOBEC3F (A3F) have been shown to inhibit the replication of HBV in vitro, but the presumably low or even absent hepatic expression of these enzymes has raised the question as to their physiological impact on HBV replication. We show that normal human liver expresses the mRNAs of APOBEC3B (A3B), APOBEC3C (A3C), A3F, and A3G. In primary human hepatocytes, interferon alpha (IFN‐α) stimulated the expression of these cytidine deaminases up to 14‐fold, and the mRNAs of A3G, A3F, and A3B reached expression levels of 10%, 3%, and 3%, respectively, relative to GAPDH mRNA abundance. On transfection, the full‐length protein A3BL inhibited HBV replication in vitro as efficiently as A3G or A3F, whereas the truncated splice variant A3BS and A3C had no effect. A3BL and A3BS were detected predominantly in the nucleus of uninfected cells; however, in HBV‐expressing cells both proteins were found also in the cytoplasm and were associated with HBV viral particles, similarly to A3G and A3F. Moreover, A3G, A3F, and A3BL, but not A3BS, induced extensive G‐to‐A hypermutations in a fraction of the replicated HBV genomes. In conclusion, the editing enzymes A3BL, A3F, and most markedly A3G, which are expressed in liver and up‐regulated by IFN‐α in hepatocytes, are candidates to contribute to the noncytolytic clearance of HBV. (HEPATOLOGY 2006;43:1364–1374.)

15 April 2004 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RSRodolphe Suspène
Rodolphe Suspène
PSPeter Sommer
Peter Sommer
MHMichel Henry
Michel Henry
SFStéphane Ferris
Stéphane Ferris
DGDenise Guétard
Denise Guétard
JVJean-Pierre Vartanian
Jean-Pierre Vartanian
In the absence of the viral vif gene, human immunodeficiency virus (HIV) may be restricted by the APOBEC3G gene on chromosome 22. The role of the HIV Vif protein is to exclude host cell APOBEC3G from the budding virion. As APOBEC3G shows sequence homology to cytidine deaminases, it is presumed that in the absence of Vif, cytidine residues in the cDNA are deaminated yielding uracil. It is not known if additional proteins mediate APOBEC3G function or if deamination occurs in concert with reverse transcription. This report describes an in vitro assay showing that Baculovirus derived APOBEC3G alone extensively deaminates cDNA independently of reverse transcriptase. It reproduces the dinucleotide context typical of G → A hypermutants derived from a Δvif virus. By using an RNaseH– form of reverse transcriptase, it was shown that the cDNA has to be free of its RNA template to allow deamination. APOBEC3G deamination of dC or dCTP was not detected. In short, APOBEC3G is a single‐stranded DNA cytidine deaminase capable of restricting retroviral replication.